Reduced pancreatic β-cell functional mass in diabetes, and other categories of glucose intolerance, has been described by several authors, and decreased islet and/or -cell volume in the pancreas of type 2 diabetic patients has been consistently reported. In addition, studies conducted in patients, and isolated islets, have shown both quantitative and qualitative defects of glucose-stimulated insulin secretion.